Word

ZYGEL

Status

Dead

Status Code

606

Status Date

Monday, March 7, 2022

Serial Number

87571145

Mark Type

4000

Filing Date

Wednesday, August 16, 2017

Published for Opposition

Tuesday, December 26, 2017

Abandoned Date

Monday, March 7, 2022

Trademark Owner History

Zynerba Pharmaceuticals, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Trademark Events

Mar 7, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 7, 2022

Abandonment - No Use Statement Filed

Jul 13, 2021

Notice Of Approval Of Extension Request E-Mailed

Jul 12, 2021

Extension 5 Granted

Jun 30, 2021

Extension 5 Filed

Jul 8, 2021

Case Assigned To Intent To Use Paralegal

Jun 30, 2021

Teas Extension Received

Jan 6, 2021

Notice Of Approval Of Extension Request E-Mailed

Jan 4, 2021

Extension 4 Granted

Jan 4, 2021

Extension 4 Filed

Jan 4, 2021

Teas Extension Received

Jun 10, 2020

Notice Of Approval Of Extension Request E-Mailed

Jun 8, 2020

Extension 3 Granted

Jun 8, 2020

Extension 3 Filed

Jun 8, 2020

Teas Extension Received

Jan 30, 2020

Notice Of Approval Of Extension Request E-Mailed

Jan 28, 2020

Extension 2 Granted

Jan 28, 2020

Extension 2 Filed

Jan 28, 2020

Teas Extension Received

Jul 23, 2019

Notice Of Approval Of Extension Request E-Mailed

Jul 19, 2019

Extension 1 Granted

Jul 19, 2019

Extension 1 Filed

Jul 19, 2019

Teas Extension Received

Jan 29, 2019

Noa E-Mailed - Sou Required From Applicant

Dec 12, 2018

Ttab Release Case To Trademarks

Dec 12, 2018

Opposition Terminated No. 999999

Dec 12, 2018

Opposition Dismissed No. 999999

Apr 25, 2018

Opposition Instituted No. 999999

Feb 14, 2018

Teas Change Of Correspondence Received

Jan 31, 2018

Assigned To Examiner

Jan 25, 2018

Extension Of Time To Oppose Received

Dec 26, 2017

Official Gazette Publication Confirmation E-Mailed

Dec 26, 2017

Published For Opposition

Dec 6, 2017

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 6, 2017

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 6, 2017

Notification Of Notice Of Publication E-Mailed

Nov 20, 2017

Approved For Pub - Principal Register

Nov 20, 2017

Assigned To Examiner

Aug 22, 2017

New Application Office Supplied Data Entered In Tram

Aug 21, 2017

New Application Entered In Tram